Anatomic Stage II Breast Cancer AJCC v8 trials recruiting in Minnesota

All Anatomic Stage II Breast Cancer AJCC v8 trials nationally

Cities in Minnesota

Recruiting trials in Minnesota

• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Brainerd, Burnsville, Chaska, Coon Rapids
• Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer
  NCT05417867 · Phase: Not specified · Ages: 20 Years and older · Sex: All (male and female) · Minnesota: Albert Lea, Mankato, Rochester
• Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
  NCT07460752 · Phase: Phase 2 · Ages: 18 Years to 50 Years · Sex: Female · Minnesota: Rochester
• ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
  NCT06876714 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Bemidji, Brainerd, Coon Rapids, Deer River
• Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
  NCT05929768 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Aitkin, Baxter, Bemidji, Brainerd
• Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
  NCT07391774 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Brainerd, Coon Rapids, Deer River, Detroit Lakes